144 related articles for article (PubMed ID: 6357805)
1. Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer.
Steiner R; Stewart JF; Cantwell BM; Minton MJ; Knight RK; Rubens RD
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1553-7. PubMed ID: 6357805
[TBL] [Abstract][Full Text] [Related]
2. Weekly adriamycin versus VAC in advanced breast cancer. A randomized trial.
Gundersen S; Kvinnsland S; Klepp O; Kvaløy S; Lund E; Høst H
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1431-4. PubMed ID: 3595668
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy versus chemotherapy plus hormonotherapy in postmenopausal advanced breast cancer patients. A randomized trial.
Viladiu P; Alonso MC; Avella A; Beltrán M; Borrás J; Ojeda B; Bosch FX
Cancer; 1985 Dec; 56(12):2745-50. PubMed ID: 3902200
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP).
Carmo-Pereira J; Costa FO; Henriques E
Cancer; 1981 Oct; 48(7):1517-21. PubMed ID: 7026020
[TBL] [Abstract][Full Text] [Related]
5. [A randomized trial comparing ACF (adriamycin, cyclophosphamide, ftorafur) and ACF/MVMF (mitomycin C, vincristine, methotrexate, ftorafur)--a non-cross-resistant alternating chemotherapy of recurrent and advanced breast cancer].
Mukaiyama T; Ogawa M; Horikoshi N; Inoue K; Tada A; Ueno K; Yamazaki H; Nakamura T; Ito Y; Inagaki J
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):327-32. PubMed ID: 2494947
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced breast cancer with two doxorubicin-containing regimens.
Harris MA; Byrne PJ; Smith FP; Ueno W; Schlesinger C; Oishi S; Schein PS
Am J Clin Oncol; 1984 Feb; 7(1):51-8. PubMed ID: 6421145
[TBL] [Abstract][Full Text] [Related]
7. A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B study.
Tormey DC; Weinberg VE; Leone LA; Glidewell OJ; Perloff M; Kennedy BJ; Cortes E; Silver RT; Weiss RB; Aisner J
Am J Clin Oncol; 1984 Jun; 7(3):231-9. PubMed ID: 6375344
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
Aisner J; Weinberg V; Perloff M; Weiss R; Perry M; Korzun A; Ginsberg S; Holland JF
J Clin Oncol; 1987 Oct; 5(10):1523-33. PubMed ID: 3655855
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer.
Rischin D; Bishop JF; Olver IN; Laidlaw CR; Zimet A; Jeal P; Dipell JF
Am J Clin Oncol; 1992 Oct; 15(5):392-4. PubMed ID: 1524039
[TBL] [Abstract][Full Text] [Related]
10. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
[TBL] [Abstract][Full Text] [Related]
11. Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF). A clinical trial of the Piedmont Oncology Association (POA).
Shipp SK; Muss HB; Westrick MA; Cooper MR; Jackson DV; Richards FC; White DR; Stuart JJ; Christian RM; Ramseur W
Cancer Chemother Pharmacol; 1983; 11(2):130-3. PubMed ID: 6354509
[TBL] [Abstract][Full Text] [Related]
12. Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group Trial.
Tormey DC; Gelman R; Band PR; Sears M; Rosenthal SN; DeWys W; Perlia C; Rice MA
Cancer; 1982 Oct; 50(7):1235-44. PubMed ID: 7049347
[TBL] [Abstract][Full Text] [Related]
13. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
Pinnamaneni K; Yap HY; Buzdar AU; Distefano A; Blumenschein GR
Cancer; 1984 May; 53(9):1841-4. PubMed ID: 6546706
[TBL] [Abstract][Full Text] [Related]
14. A randomized, prospective, comparative, multicentre trial of a single combination versus alternating combinations of antitumour drugs in advanced breast cancer.
Spittle MF; Hill BT; Ostrowski MJ; Macrae KD; Bates TD; Martin WM; Nicol NT; Edelstyn GA
Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1155-62. PubMed ID: 3308483
[TBL] [Abstract][Full Text] [Related]
15. Combination of cyclophosphamide, adriamycin and platinum (CAP) versus 5-fluorouracil, adriamycin and cyclophosphamide (FAC) as primary treatment in metastatic breast cancer: results of a prospective randomized study.
Kolarić K; Vukas D; Potrebica V
Tumori; 1989 Apr; 75(2):132-6. PubMed ID: 2741218
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy of dibromodulcitol, Adriamycin, vincristine, tamoxifen, and Halotestin with methotrexate in metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1181).
Chang AY; Putt M; Pandya KJ; Harris J; Gelman R; Tormey DC; Falkson G
Am J Clin Oncol; 1998 Feb; 21(1):99-104. PubMed ID: 9499270
[TBL] [Abstract][Full Text] [Related]
17. A comparison of continuation versus late intensification followed by discontinuation of chemotherapy in advanced breast cancer. A prospective randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Cocconi G; Bisagni G; Bacchi M; Buzzi F; Canaletti R; Carpi A; Ceci G; Colozza A; De Lisi V; Lottici R
Ann Oncol; 1990; 1(1):36-44. PubMed ID: 2078484
[TBL] [Abstract][Full Text] [Related]
18. The effects of multiple combination chemotherapy with vincristine, cyclophosphamide (Endoxan), methotrexate, 5-fluorouracil, adriamycin and prednisolone (VEMFAH) for advanced breast cancer.
Kojima T; Hoshino A; Ohara K; Kamiya O; Nagata K; Ito Y; Kinoshita T; Sugiura I; Yamada M; Sato H
Cancer Chemother Pharmacol; 1985; 15(3):268-71. PubMed ID: 3902267
[TBL] [Abstract][Full Text] [Related]
19. A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study.
Pannuti F; Iafelice G; Martoni A; Fruet F; Angelelli B; Casadei M
Chemioterapia; 1984 Aug; 3(4):216-9. PubMed ID: 6398121
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy with or without tamoxifen in postmenopausal patients with late breast cancer. A randomized study.
Boccardo F; Rubagotti A; Rosso R; Santi L
J Steroid Biochem; 1985 Dec; 23(6B):1123-7. PubMed ID: 3912616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
